Parks Anna L, Fang Margaret C
Department of Medicine, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143, USA.
Division of Hospital Medicine, University of California, San Francisco, 533 Parnassus Avenue, Box 0131, San Francisco, CA 94143, USA.
Clin Geriatr Med. 2016 May;32(2):331-46. doi: 10.1016/j.cger.2016.01.003. Epub 2016 Feb 19.
The number of patients with atrial fibrillation (AF) who are of advanced age or have multiple comorbidities is expected to increase substantially. Older patients with AF generally gain a net benefit from anticoagulation. Guidelines typically recommend anticoagulation. There are multiple challenges in the safe use of anticoagulation in frail patients, including bleeding risk, monitoring and adherence, and polypharmacy. Although there are options for chronic oral anticoagulation, clinicians must understand the unique advantages and disadvantages of these medications when developing a management plan. This article reviews issues surrounding the appropriate use and selection of anticoagulants in complex older patients with AF.
预计高龄或患有多种合并症的心房颤动(AF)患者数量将大幅增加。老年房颤患者通常从抗凝治疗中获得净获益。指南通常推荐进行抗凝治疗。在体弱患者中安全使用抗凝药物存在多重挑战,包括出血风险、监测与依从性以及多重用药问题。尽管有多种慢性口服抗凝药物可供选择,但临床医生在制定管理计划时必须了解这些药物的独特优缺点。本文综述了复杂老年房颤患者抗凝药物合理使用与选择的相关问题。